Not checked for notices yet.
Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience
Aaron E. Miller
Therapeutic Advances in Neurological Disorders · 2017
doi:10.1177/1756285617722500 (opens in a new tab)
Cited by papers we hold 1
- Immunological Aspects of Approved MS Therapeutics · 2019No notice
Questions about this paper
We email you if it is retracted, withdrawn, corrected or flagged.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.